Kristian A. Werling
McDermott Will & Emery LLP
Kristian Werling (Krist) is a partner in the law firm of McDermott Will & Emery LLP and is based in the Firm’s Chicago office. He focuses his practice on representing clients in the life sciences and health industries, including medical device manufacturers, pharmaceutical manufacturers and healthcare service providers, in a wide variety of transactional matters. He is part of the team at McDermott named in 2016 as one of the nation’s top five law firms “most active and relevant for life science companies” in the inaugural Life Sciences Law Firm Index sponsored by Lake Whillans.
Concomitant with his practice in the contemporary landscape of healthcare and life sciences is a related depth of experience in representing private equity and venture capital investors. In this capacity he works with cross-disciplinary teams to conduct legal due diligence and execute acquisitions, add-on acquisitions and divestitures, as well as provide ongoing legal services to portfolio companies.
Krist provides transactional and regulatory counseling to a wide variety of pharmaceutical, biotechnology and medical device clients, including Baxter International, Baxalta, AbbVie, Varian Medical Systems, C.R. Bard, Amsino International, Medical Specialties Distributors, Jace Biomedical, Hill-Rom, Nexus Pharmaceuticals and Breg.